irritable%20bowel%20syndrome
IRRITABLE BOWEL SYNDROME
Irritable bowel syndrome is a common chronic gastrointestinal condition characterized by abdominal pain and bloating with altered bowel habits.
There are no identifiable physical, radiologic or lab abnormalities indicative of organic disease.
Symptoms may be exacerbated by stress, alcohol or food.

Irritable Bowel Syndrome Drug Information

Drug Information
Bioflor
Saccharomyces boulardii

Indication: Acute infectious diarrhoea in infants, childn & adults. Prevention of antibiotic-associated diarrhoea in c...

Indication: Chronic constipation; pre-coma & coma hepaticum.

Agiolax
plantago ovata husks + plantago seeds + sennosides

Indication: Traditionally used for constipation.

Indication: Symptomatic treatment & relief associated w/ irritable bowel syndrome (abdominal pain, bowel disturbances ...

Indication: Symptomatic treatment of abdominal pain & cramps, bowel disturbances & intestinal discomfort related t...

Indication: Symptomatic control of acute & chronic diarrhea; reduce number & vol of stools & harden their cons...

Indication: Relief of constipation & helps in stool softening. Hepatic encephalopathy.

Indication: GIT & GUT spasm, biliary system spasm & dyskinesia.

Indication: Acute spasm, as in renal or biliary chronic, in radiology for differential diagnosis of obstruction. Reduction...

Forlax
macrogol 4000

Indication: Symptomatic treatment of constipation in adults & childn ≥8 yr.

1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
2 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 6 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).